Clinical trial Recruiting at 2 sites Observational Ages 2 to 17

Evaluating sleep tracker accuracy in children

Official title: The Sweet Dreams Study - Accuracy of Sleep Trackers in Children

Run by Arkansas Children's Hospital Research Institute · NCT06787378 · Data updated 2026-11-12

This study is testing how accurate sleep trackers are for children aged 2 to 17 by comparing their results to a standard sleep test.

More Obstructive Sleep Apnea trials

Quick facts

Study typeObservational
Ages2 Years to 17 Years
SexAll
Enrollment300 (estimated)
SponsorArkansas Children's Hospital Research Institute
Academic / other
Locations2 sites (Little Rock, Arkansas and 1 other locations)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedFebruary 28, 2029
Study endsFebruary 28, 2029
Registry record updatedApril 3, 2025
Trial IDNCT06787378 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 2 to less than 18 years who are scheduled for evaluation of obstructive sleep apnea, snoring, or noisy breathing during sleep.

Probably not a fit

Patients with known sleep disorders or certain neurological and mental health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the accuracy of sleep trackers in children aged 2 to less than 18 years by comparing their data with results from polysomnography, the gold standard for assessing sleep quality. Participants will wear sleep trackers during their scheduled sleep tests at Arkansas Children's Hospital. The study will also gather information about the child's home environment, medical history, and conduct a brief physical exam. The goal is to determine how well these devices can measure sleep patterns in children.

Why it matters

Potential benefit: If successful, this study could provide insights into the reliability of sleep trackers, potentially leading to better sleep monitoring for children.

How similar studies have gone: Other studies have shown varying degrees of success in evaluating sleep tracker accuracy, but this specific approach in children is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 2 to \<18 years
* All BMIs
* Scheduled at PSDC for evaluation of obstructive sleep apnea, snoring, or noisy breathing during sleep.

Exclusion Criteria:

* Known diagnosis of sleep disorder
* Neurological disorders (e.g., epilepsy, cerebral palsy, etc.)
* Autism spectrum disorder
* Attention deficit hyperactivity disorder
* Oppositional defiant disorder
* Chronic kidney disease
* Hormonal disease
* Autoimmune diseases
* Bleeding disorders
* Chronic infections (e.g., HIV, hepatitis B)
* Mental health disorders (e.g., depression, anxiety)
* Liver disease (e.g. hepatitis)
* Referral for evaluation of disorders other than obstructive sleep apnea, snoring, or noisy breathing during sleep.
* Pre-existing medical conditions or medications as determined by the investigators to affect the outcomes of interest.
* Refusal to authorize study investigators to access data from the polysomnography test conducted at the Arkansas Children's Hospital PSDC.

Where it's running

  • Arkansas Children's Hospital
    Little Rock, Arkansas, United States
    Recruiting
  • Arkansas Children's Nutrition Center
    Little Rock, Arkansas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.